Contraceptive use Not Applicable
Conditions
Interventions
The study domain included two primary health care units (PHCU) from two districts from each of the four regions where JSI was implementing a family planning program. From each region one PHCU was rand
2) client care checklist to ensure proper counselling of clients
and 3) an appointment card to be given to the family planning client as a reminder of the next does of injectable relating the date with religious events. Based on the study participation eligibility
Sponsors
JSI Research & Taining Institute, Inc.
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Women of reproductive age who visited the study area health posts during the intervention period and fulfilled any of the following three criteria 1.1 Initiating use of injectable contraceptives 1.2 Returning to the use of injectable contraceptives after at least a six-month lapse 1.3 Switching to injectable contraceptives from another family planning method
Exclusion criteria
Exclusion criteria: 1. Not a family planning client 2. Using other methods of contraceptives 3. Other method users not planning to switch to injectable contraceptives 4. Already an injectable contraceptive client before the study period
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Injectable contraceptive discontinuation rate within 12 months of uptake. To measure the primary outcome of interest, i.e., the injectable contraceptive discontinuation rate within 12 months of uptake, first the duration of injectable contraceptive use was measured from the three survey items: (1) the month and year the eligible participant visited the health post between intervention onset and November 2016 (uptake month); (2) whether the participant was still using the injectable contraceptive without interruption at the time of the survey, or with a maximum of a month (30 days) of interruption (survey month); and (3) if the participant was not currently using the injectable contraception, then the month and year the participant had last obtained injectable contraceptive without interruption or with a maximum of one month of interruption (dropout month). The duration of injectable contraceptive use from uptake is the difference between uptake month and survey month, or uptake month and dropout month. The duration was measured in months. In a few of the dropout cases, where the participant could not accurately describe the last time she obtained an injectable contraceptive (without interruption), then the duration of use was obtained by asking how long (in months) she had used injectable contraception without interruption. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Mean number of correct side effects of injectable contraceptive spontaneously recalled by the participant 2. Mean number of different types of contraceptive methods spontaneously recalled by the provider 3. Mean number of correct actions to be taken spontaneously recalled by the participant if she experienced side effects from injectable contraceptives 4. Whether the participant was told about the side effects of injectable contraceptives by the provider 5. Whether the participant was told what to do if she experienced side effects 6. Whether the participant was informed about other methods of contraception 7. Whether the participant was told, during her last visit to the health post for injectables, about a local holiday or event as a reminder of the next appointment date 8. Whether the participant was given an appointment card during the last visit to obtain an injectable contraceptive 9. Whether the participant missed an appointment for injectable contraceptives. | — |
Countries
Ethiopia
Outcome results
None listed